Financiado en parte por Nutrabolt International
Acute and chronic safety and efficacy of dose dependent creatine nitrate supplementation and exercise performance
Galvan E, Walker DK, Simbo SY, Dalton R, Levers K, O'Connor A, Goodenough C, Barringer ND, Greenwood M, Rasmussen C, Smith SB, Riechman SE, Fluckey JD, Murano PS, Earnest CP, Kreider RB
Journal of the International Society of Sports Nutrition · 31 citas
Etiquetas de revisión
Financiado por la industriaDatos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.
Cómo se estudió
- Diseño
- Ensayo controlado aleatorizado (indexado por PubMed)
- Estudiado en
- Personas
- Resultado principal
- Marcadores de salud y funcionamiento
Quién lo pagó
- Financiación
- Financiado por la industria
- Empresa
- Nutrabolt International
Según 1 financiador declarado.
Publicación
- Publicado
- 2016-01-05 · J Int Soc Sports Nutr · vol. 13 · número 1 · pág. 12
- Editorial
- Springer Science+Business Media
- Citado
- 41 citas · más que el 78% de estudios similares · 1.4× el promedio de su campo
- Referencias
- 34 trabajos
- Acceso
- Acceso abierto (revista) · CC-BY
- Áreas de investigación
- Muscle metabolism and nutrition · Exercise and Physiological Responses · Cardiovascular and exercise physiology
- Palabras clave
- Medicine, Creatine Monohydrate, Creatine, Crossover study, Placebo, Internal medicine, Sprint, Bench press, Physical therapy, Sports medicine, Wingate test, Phosphocreatine, Anaerobic exercise
- MeSH
- muscle, skeletal, humans, nitrates, creatine, cross-over studies, double-blind method, anaerobic threshold, blood pressure, heart rate, physical endurance, dose-response relationship, drug, weight lifting, physical fitness, dietary supplements, adult, male, muscle strength, athletic performance
16 autores
- Elfego Galvan🇺🇸Texas A&M University
- Dillon K. Walker🇺🇸Texas A&M University
- Sunday Y. Simbo🇺🇸Texas A&M University
- R Dalton🇺🇸Texas A&M University
- Kyle S. Levers🇺🇸Texas A&M University
- A O’Connor🇺🇸Texas A&M University
- Chelsea Goodliffe Goodenough🇺🇸Texas A&M University
- N Barringer🇺🇸Baylor University
- Mike Greenwood🇺🇸Texas A&M University
- Christopher J. Rasmussen🇺🇸Texas A&M University
- Stephen Brent Smith🇺🇸Texas A&M University
- Steven E. Riechman🇺🇸Texas A&M University
- James D. Fluckey🇺🇸Texas A&M University
- Peter S. Murano🇺🇸Texas A&M University
- Conrad P. Earnest
- Richard B. Kreider🇺🇸 · autor de correspondenciaTexas A&M University
Resumen
El texto original del estudio, en el idioma en que se publicó.
Background
Creatine monohydrate (CrM) and nitrate are popular supplements for improving exercise performance; yet have not been investigated in combination. We performed two studies to determine the safety and exercise performance-characteristics of creatine nitrate (CrN) supplementation.
Methods
Study 1 participants (N = 13) ingested 1.5 g CrN (CrN-Low), 3 g CrN (CrN-High), 5 g CrM or a placebo in a randomized, crossover study (7d washout) to determine supplement safety (hepatorenal and muscle enzymes, heart rate, blood pressure and side effects) measured at time-0 (unsupplemented), 30-min, and then hourly for 5-h post-ingestion. Study 2 participants (N = 48) received the same CrN treatments vs. 3 g CrM in a randomized, double-blind, 28d trial inclusive of a 7-d interim testing period and loading sequence (4 servings/d). Day-7 and d-28 measured Tendo™ bench press performance, Wingate testing and a 6x6-s bicycle ergometer sprint. Data were analyzed using a GLM and results are reported as mean ± SD or mean change ± 95 % CI.
Results
In both studies we observed several significant, yet stochastic changes in blood markers that were not indicative of potential harm or consistent for any treatment group. Equally, all treatment groups reported a similar number of minimal side effects. In Study 2, there was a significant increase in plasma nitrates for both CrN groups by d-7, subsequently abating by d-28. Muscle creatine increased significantly by d-7 in the CrM and CrN-High groups, but then decreased by d-28 for CrN-High. By d-28, there were significant increases in bench press lifting volume (kg) for all groups (PLA, 126.6, 95 % CI 26.3, 226.8; CrM, 194.1, 95 % CI 89.0, 299.2; CrN-Low, 118.3, 95 % CI 26.1, 210.5; CrN-High, 267.2, 95 % CI 175.0, 359.4, kg). Only the CrN-High group was significantly greater than PLA (p < 0.05). Similar findings were observed for bench press peak power (PLA, 59.0, 95 % CI 4.5, 113.4; CrM, 68.6, 95 % CI 11.4, 125.8; CrN-Low, 40.9, 95 % CI -9.2, 91.0; CrN-High, 60.9, 95 % CI 10.8, 111.1, W) and average power.
Conclusions
Creatine nitrate delivered at 3 g was well-tolerated, demonstrated similar performance benefits to 3 g CrM, in addition, within the confines of this study, there were no safety concerns.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial (CC BY).
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.